AJP - Renal Journal of Neurophysiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 274: F197-F204, 1998;
0363-6127/98 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilfiker, H.
Right arrow Articles by Murer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilfiker, H.
Right arrow Articles by Murer, H.
Vol. 274, Issue 1, F197-F204, January 1998

Characterization of the 5'-flanking region of OK cell type II Na-Pi cotransporter gene

Helene Hilfiker, Claudia M. Hartmann, Gerti Stange, and Heini Murer

Department of Physiology, University of Zurich, CH-8057 Zurich, Switzerland

    ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

The renal type II Na-Pi cotransport is the rate-limiting step in proximal tubular phosphate (Pi) reabsorption. Among the different "proximal tubular" cell lines, this transporter seem only to be expressed in opossum kidney cells (OK cells). We have isolated the 5'-flanking region of the ok-Npt2 gene (OK cell type II Na-Pi cotransporter) including exons 1-3 and containing a TFIID site (TATA box), a GCCAAT site, an AP1 site, and two microsatellite GGAA repeats. Major transcription initiation sites were determined by primer extension and rapid amplification of 5' cDNA ends (5'-RACE). A 327-bp fragment containing the TFIID and GCAAT element was driving the downstream luciferase reporter gene in homologous transfection assays. Slightly reduced promoter activity was observed with a 198-bp fragment containing the GCAAT element; shorter fragments were without activity. Promoter activity (327-bp fragment) could also be observed in transfections into HeLa cells but not in U937 human macrophage cells, MCT mouse kidney cortex cells, and MDCK cells. Different "physiological" stimuli known to be associated with altered proximal tubular Na-Pi cotransport activity are without effect on transcriptional activity in above homologous transfection experiments.

renal phosphate transporter; promoter; brush-border membrane; parathyroid hormone

    INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

PHOSPHATE (Pi) reabsorption in the mammalian proximal tubule is altered under a variety of physiological and pathophysiological conditions (for review, see Refs. 3, 6, 22). Brush-border membrane Na-Pi cotransport was found to be the rate-limiting and pathophysiologically altered transport step. Two different brush-border membrane Na-Pi cotransporters have been identified by expression cloning techniques. Both, the type I and type II transporters were found to be exclusively located in the proximal tubule (for review, see Refs. 13, 19-21).

The type II Na-Pi cotransporter was identified from different animal species (9, 11, 16, 27, 29, 30, 32), including the opossum kidney-derived OK cell line (NaPi-4, Ref. 27), the only renal cell model expressing this transporter in significant amounts and frequently used to dissect the cellular and regulatory mechanisms involved in regulation of proximal tubular brush-border membrane Na-Pi cotransport (for review, see Ref. 22). The type II Na-Pi cotransporter is altered under a variety of physiological and pathophysiological conditions (for reviews, see Refs. 13, 19-21). Such regulatory phenomena were also seen in OK cells, for example, for parathyroid hormone (PTH; 5, 17, 23a), for alterations in the medium phosphate content (4, 18, 25, 26), for glucocorticoids (31), for thyroid hormone [triiodothyronine (T3); see Ref. 28], and for epidermal growth hormone (1).

The gene structure for the human and murine type II Na-Pi cotransporter gene (NPT2 and m-Npt2) has recently been determined (8). In the present study, we report the isolation and characterization of the 5'-flanking region of the OK cell type II Na-Pi cotransporter (ok-Npt2). We demonstrate that the ok-Npt2 promoter is active in the homologous OK cell system and hardly regulated by PTH or changes in the phosphate concentration in the medium.

    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Materials. Restriction enzymes were obtained from Biofinex (Switzerland); DNA modifying enzymes, pGL3 luciferase reporter gene plasmids, and luciferase reporter gene assay were from Promega (Madison, WI); pBluescript SK+ plasmid was acquired from Stratagene (La Jolla, CA); pCMV-LacZ was kindly provided by Dr. S. Rusconi, University of Zurich, Switzerland; pUC19 Nco I was obtained from Dr. H. Rhyner, Children's Hospital of Zurich, Switzerland; [alpha -32P]dCTP, [alpha -35S]dATP, and [gamma -32P]ATP were purchased from NEN Research Products (Du Pont Canada) and oligonucleotides were synthesized by Microsynth.

Gene isolation and mapping. Genomic DNA from cultured OK cells (3B/2 clone) was extracted and dialyzed according to current protocols (2). A genomic Southern blot was hybridized with a 32P-labeled 5' end probe (oligolabeling kit, Pharmacia) isolated from OK cell NaPi-4 cDNA (27) in pSPORT1 (560-bp Mlu I-Sac I, see Fig. 1) overnight at 42°C in 50% formamide solution supplemented with 5% dextran sulfate (2). The filter was washed twice with 2× SSC (1× SSC is 0.15 M NaCl and 0.015 M sodium citrate, pH 7.0)-0.1% sodium dodecyl sulfate (SDS) at room temperature and twice with 0.5× SSC-0.1% SDS at 55°C and exposed on Kodak films with intensifying screen. A 12- to 15-kb BamH I genomic fragment could be detected on the genomic Southern blot. For construction of a library, OK cell genomic DNA was digested with BamH I and size fractionated on a 10-40% sucrose gradient. A fraction of 12-20 kb was ligated into lambda DASH II-BamH I (Stratagene), and 106 plaque-forming units were screened with the probe mentioned above. A genomic clone of ~14 kb (lambda OKGL41.1, see Fig. 1) was isolated. A 6,000-bp EcoR I-BamH I fragment was subcloned into pBluescript SK+ (Stratagene). The DNA was purified in small quantities by spin columns (Qiagen).


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Genomic organization of OK cell Npt2 (ok-Npt2). A genomic BamH I clone of 14 kb (lambda OKGL41.1) was isolated from a OK cell lambda DASH II library. A 6,000-bp EcoR I-BamH I subfragment was cloned into pBluescript SK+ and sequenced. It contained exons 1 to 3 (solid boxes), introns 1 to 3 (open boxes), and 4.7 kb of 5'-flanking region. A consensus binding site for TFIID (TATA box) at -30 and a "GCAAT" element at -124 were identified. The 5'-flanking region as well as intron 3 of the OK cell Npt2 gene exhibit long GGAA repeats of unknown function (microsatellites; gray shaded boxes). Top: the 560-bp Mlu I-Sac I cDNA probe used for screening the lambda DASH II library; the polylinker is depicted as solid black, the 5' untranslated region is shaded in gray, and the coding region is open. Bottom: different constructs used for the analysis of promoter function; fragments of different size ranging from -4700 to -67 and including 54 bp of exon 1 have been cloned in front of the luciferase reporter gene of pGL3 basic (Promega) to estimate the corresponding transcriptional activity.

The DNA was sequenced on both strands by the dideoxynucleotide chain termination method (Pharmacia Kit) and analyzed using the University of Wisconsin Genetics Computer Group Software, version 8.1.

Cell culture. The opossum kidney proximal tubule cell line (3B/2) and the human HeLa-S3 cell line were grown in Dulbecco's modified Eagle's medium-Ham's F12 (DMEM-F12) supplemented with 10% fetal calf serum (FCS) and 2 mM L-glutamine. The human macrophage cell line U937, the Madin-Darby canine kidney (MDCK) cell line, and the mouse kidney cortex cell line MCT (10) were cultivated in DMEM supplemented with 10% FCS. All cell cultures were kept at 37°C in a humidified environment (5% CO2, 95% air).

ok-Npt2 promoter-luciferase constructs: electroporation and enzyme assays. A 327-bp genomic fragment was generated by polymerase chain reaction (PCR) on the 6,000-bp EcoR I-BamH I subfragment of clone lambda OKGL41.1 with an antisense primer localized within exon 1 (NaPi4-31/50R, see Fig. 2) and a sense primer starting at position -327 on the ok-Npt2 gene. The fragment was digested with Apa I (located in the 5'-flanking region of ok-Npt2), subcloned into pBluescript SK+ cut with Apa I and Sma I (pB327), and sequenced. To generate the luciferase reporter gene construct pGL327, the insert was excised from pB327 by BamH I and Kpn I (both located within the polylinker of pBluescript SK+) and subcloned into pGL3 basic vector digested by Kpn I and Bgl II. Genomic DNA fragments of 140 to 208 bp were generated by PCR on pB327 (mentioned above) with a pBluescript SK+ primer (5' CCATGATTACGCCAAGCTC 3') and different ok-Npt2-specific sense primers. The construct pGL208 extends from position -154, pGL206 from -152, pGL198 from -144, pGL194 from -140, pGL173 from -119, pGL168 from -114, pGL140 from -86 and pGL121 from -67, and the whole set of PCR generated fragments end within exon 1 at position +54. The amplified DNA was digested with BamH I (located in the polylinker of pBluescript SK+), subcloned into the pGL3 basic vector digested with Bgl II and Sma I, and sequenced on both strands.


View larger version (84K):
[in this window]
[in a new window]
 
Fig. 2.   Sequence of the 5'-flanking region of the OK cell Npt2 gene (ok-Npt2). This 3,017-bp sequence is part of the 6,000-bp EcoR I-BamH I fragment (see Fig. 1), which has been sent to the GenBank/EMBL Data Bank (6 kb of sequence; accession no. AJ003021). The first nucleotide corresponding to the OK cell NaPi-4 cDNA is depicted as +16, and the main transcription start site is at +1. Exons 1-3 are underlined, and coding sequence is in uppercase letters. Translation start site (double underlined) is located within the second exon. A possible TFIID binding site and the conserved GCAAT element are boxed in bold. A potential AP1 site at -304 is underlined. The two microsatellite GGAA repeats of unknown function are in italic lowercase. The 3' end primer (NaPi4-31/50R) used for generation of the OK cell promoter constructs is marked in the gray shaded box.

The luciferase reporter gene constructs pGL1700 and pGL4700 were generated by linking a 1,400-bp Sac I-Apa I or a 4,400-bp EcoR I-Apa I subfragment of clone lambda OKGL 41.1 to the 327-bp Apa I-BamH I fragment mentioned above.

For standardization of the promoter activity in different cell lines, the pGL3 promoter (pGL3-SV40, enhancerless simian virus promoter) and the pGL3 basic vector (Promega) were used. As internal standard, a beta -galactosidase-expressing vector pCMV-LacZ was cotransfected. Transient cell transfections were performed by electroporation. Approximately 107 cells in DMEM without FCS were electroporated at 960 µF and 250 V with 5 µg (OK cells), 10 µg (MCT, MDCK and U937), or 20 µg (HeLa-S3) of pGL3 constructs and equal amounts of pCMV-LacZ and plated on 3.5-cm diameter dishes. The cells were harvested 48 h after transfection in 100 µl of 1× lysis buffer (Promega). The beta -galactosidase reaction was performed in 0.1 M NaPO4, pH 7.5, 4 mg/ml o-nitrophenyl-beta -galactopyranoside, and 1 mM MgCl2 for 30 min to 4 h at 37°C, and the optical density was measured at 420 nm. Luciferase was assayed with a luciferase kit (Promega) and measured in a luminometer (Lumac Biocounter M1500).

For studies related to the effect of PTH and phosphate concentration, the electroporated cells were plated into 24-well plates in triplicate and kept for 4 h in DMEM-F12 supplemented with 10% FCS to improve vitality. Subsequently cultured cells were switched for 24 h to the corresponding medium (22 mM HCO<SUP>−</SUP><SUB>3</SUB>, 5% CO2, and pH 7.4) without FCS. For studies with altering phosphate concentration, cells were kept in phosphate-free DMEM (Sigma) supplemented with 0.1, 0.9, and 1.5 mM phosphate. To determine the hormonal effect, the cells were either incubated in 10-8 M PTH or in its vehicle. The cells were used for uptake studies and then harvested in the reporter gene lysis buffer for determination of luciferase and beta -galactosidase activity. Protein concentration and Pi uptake was performed as described (23a).

Rapid amplification of 5' cDNA ends (5'-RACE). For 5'-RACE OK cell total RNA (10 µg) isolated with Trizol (GIBCO-BRL) was retrotranscribed with 20 U Moloney murine leukemia virus reverse transcriptase (MLV-RT, Promega) using a NaPi-4 cDNA-specific (OK cell; Ref. 27) primer (nt 386-405; antisense). The product was cleaned by the GeneClean II kit (BIO 101). The 5' end of the cDNA was extended by a polynucleotide transferase (30 U, GIBCO-BRL) in presence of 0.4 mM dATP. PCR was performed with a second NaPi-4 cDNA-specific primer (nt 276-291; antisense), a T17 adapter primer, and an adapter primer (7). The PCR product was digested with Sal I (located in the adapter primer) and Nco I (NaPi-4 cDNA) and subcloned into pUC19 Nco and sequenced. By this method we obtained four different extension products (see RESULTS).

Primer extension. A quantity of 10 µg of OK cell total RNA (see above) was retrotranscribed with 20 U MLV-RT (Promega) in presence of 80,000 cpm of a 32P-labeled 5' NaPi-4 cDNA-specific (OK cell; Ref. 27) primer (nt 45-65 or nt 50-70, both antisense). Labeling of the oligonucleotide was performed with 8 U polynucleotide kinase (Promega) in presence of 50 µCi [gamma -32P]ATP. The extension product was ethanol precipitated and loaded on a 6% sequencing gel in presence of a sequencing ladder performed with the primers mentioned above on genomic DNA (pGL327).

    RESULTS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Structure of the OK cell type II Na/Pi-cotransporter (Npt2) 5'-flanking region. The organization of the ok-Npt2 promoter region was determined by screening a genomic OK cell lambda DASH BamH I library with a 560-bp Mlu I-Sac I fragment representing the very 5' end of the OK cell type II Na-Pi cotransporter cDNA (see Fig. 1). A single clone lambda OKGL41.1 of ~14 kb was obtained, and a 6,000-bp EcoR I-BamH I subfragment was subcloned into plasmid pBluescript SK and fully sequenced (see Figs. 1 and 2). It contained in its 3' region exon 1 corresponding to nt 12-64, exon 2 corresponding to nt 65-177, and exon 3 corresponding to nt 178-333 of the OK cell NaPi-4 cDNA (27). A comparison of the intron/exon boundaries is presented in Table 1. In ok-Npt2, exon 2 contains only 1 base of 5'-untranslated region, in contrast to the m-Npt2 and h-NPT2 where the translation initiation site is also on exon 2 but further downstream (8). A high homology in the organization between mouse, human, and opossum NPT/Npt2 genes is suggested by the identity of encoded amino acids and coding phase usage at the intron/exon boundaries (Table 1; introns 2 and 3).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Location of donor/acceptor sites for the first 3 exons of the OK cell, human, and murine Npt2 gene

The promoter region of the ok-Npt2 gene reveals a homology of ~56% if compared with the first 170 bp of the murine or the human promoter (8). Two highly conserved regions can be observed, with one representing a classic TATA box (TFIID binding element) and the other a GCAAT element. Both are located at a similar position within the type II Na-Pi cotransporter promoters (see Fig. 3). An AP1 binding site (see Fig. 2, at -304, underlined) but no classic Sp1 binding site, glucocorticoid (GRE), T3 (TRE), or vitamin D3 (VDRE) responsive elements could be detected. (A quantity of 6 kb of 5'-flanking sequence have been analyzed for ok-Npt2; GenBank/EMBL Data Bank; accession no. AJ003021).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 3.   Sequence comparison of the 5'-flanking regions of the OK cell (ok-), human (h-), and the murine (m-) Npt2. Comparison of the first 170 bp of the OK cell, the human, and the murine promoter including the first exon reveal sequence homology (*) around a GCAAT element and a conserved TFIID binding site (both boxed and underlined). Transcription initiation sites of the ok- and m-NPT2 gene determined by both rapid amplification of 5' cDNA ends (5'-RACE) and primer extension are underlined. Exon 1 of the OK cell, human, and murine type II Na-Pi cotransporter gene is depicted in uppercase letters; +1, the major transcription initiation site in ok-Npt2; and +16, the start of the cDNA previously identified (27).

Transcription initiation site. To map the transcription initiation site of the ok-Npt2 gene, both 5'-RACE and primer extension were performed. For primer extension, two 21-mer reverse primers were tested (nt 45-65 of the NaPi-4 cDNA, results shown in Fig. 4, and nt 50-70, not shown). In both cases the autoradiogram of the extended fragments showed three major transcription start sites at +1, +2, and +5. Additional transcription initiation sites could be observed by performing 5'-RACE on OK cell total RNA at position +4 (see Fig. 4).


View larger version (67K):
[in this window]
[in a new window]
 
Fig. 4.   Determination of the transcription initiation site by primer extension (arrowheads) and by 5'-RACE (asterisks), for comparison. Sequence corresponding to the OK cell NaPi-4 cDNA (starting at +16) is given in bold, potential transcription initiation sites as obtained by primer extension are marked by arrows, and those obtained from sequencing 5'-RACE products are indicated by asterisks. For further details see MATERIALS AND METHODS.

5' Deletion analysis of the ok-Npt2 promoter in OK cell line 3B/2. Different constructs of 5' truncated promoter fragments containing 121 to 4700 bp and comprising at least the TATA box and part of the untranslated exon 1 (nt 12-50 of the NaPi-4 cDNA of OK cells) were cloned in front of the promoterless luciferase reporter gene of the pGL3-basic vector (Promega) and designated pGL121 to pGL4700 (See Figs. 1 and 5). The reporter gene constructs comprising 194 to 4700 bp showed a similar luciferase activity in transiently transfected OK cells, whereas for the shorter fragments missing the conserved GCAAT element (see Fig. 1) the promoter activity was nearly abolished and similar to the promoterless basic vector (see Fig. 5).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 5.   ok-Npt2 promoter activity in the OK cell line 3B/2. Fragments of different size ranging from -4700 to -67 and all including 54 bp of exon 1 (see Fig. 1) were subcloned into the luciferase reporter vector pGL3 to estimate the corresponding transcriptional activity. The fragments missing the GCAAT element, pGL121 to pGL173, were similar to the promoterless pGL3 construct in activity measurements. The larger fragments including the conserved GCAAT region pGL194 to pGL4700 had activities similar to the enhancerless pGL3-SV40 promoter construct. At least 3 independent experiments were done in triplicate.

Comparative analysis of ok-Npt2 promoter activity in different eukaryotic cell lines. The construct pGL327, which showed full promoter activity in OK cells (see Fig. 5), was tested in the human cell line HeLa-S3, in the U937, the MDCK, and the MCT cell lines (Fig. 6). The promoter was inactive in the murine kidney cell line MCT, in the canine kidney cell line MDCK, and in the human cell line U937. In agreement with this observation no transcription product of an intrinsic type II Na-Pi cotransporter could be obtained by RT-PCR in MCT and U937 cells (data not shown); in MDCK cells Northern hybridizations were unable to document the existence of this transporter (data not shown). Surprisingly, in the human cell line HeLa-S3 the ok-Npt2 promoter was active to a similar extent as in OK cells if compared with the pGL3-SV40 promoter (Fig. 6, A-E), although in this cell line type II Na-Pi cotransporter mRNA could not be detected by RT-PCR (data not shown).


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 6.   Analysis of the OK cell Npt2 promoter in different cell lines. The promoterless luciferase constructs pGL3, the OK cell promoter construct pGL327 (see Fig. 1), and the enhancerless SV40 promoter construct pGL3-SV40 were electroporated in different cell lines (A-E) in presence of the pCMV-LacZ vector for standardization. Luciferase and galactosidase activities were measured 48 h posttransfection. High activity of the OK cell promoter could be observed in the homologous system of OK cells (A) and in human HeLa cells (B). In the human macrophage cell line U937 (C), in the murine kidney cell line MCT (D), and the canine renal distal tubular cell line MDCK (E), the OK cell promoter had only a low activity. For each cell line data from 3 independent experiments done in triplicate were used.

Functional analysis of the ok-Npt2 promoter. The phosphate content of the medium has been shown to play a regulatory role on type II Na-Pi cotransporter expression in OK cells (4, 18, 24-26). In low-phosphate medium, the Na-Pi cotransport activity is upregulated. The experiments performed previously in our laboratory suggested that this effect is independent of an activation of transcription and might be related to an altered mRNA processing (4, 18). In accordance to our previous results (4, 18), the constructs pGL327 and pGL4700 did not respond to a shift from normal DMEM-F12 to high-phosphate (1.5 mM), normal (0.9 mM), or low-phosphate (0.1 mM) DMEM medium for 24 h (Fig. 7B).

It should be indicated that Saxena and co-workers (25, 26) have recently reported that with their OK cells the adaptive response in transport and specific mRNA content was prevented by actinomycin D. We cannot explain this apparent discrepancy in the data obtained by the two laboratories. PTH has been shown to downregulate the activity of the type II Na-Pi cotransporter protein in the OK cell line (5, 17, 23a). Studies on rats have shown a small decrease in NaPi-2 mRNA content in response to acute PTH administration (12). We have recent provided evidence that the downregulatory effect in OK cells might be due to internalization and subsequent degradation of the type II Na-Pi cotransporter (23). To test for an effect of PTH on the ok-Npt2 promoter activity, we have transiently transfected OK cells with the ok-Npt2 luciferase reporter gene constructs and incubated them in FCS-free DMEM-F12 supplemented with PTH (10-8 M) for 24 h. PTH had no downregulatory effect on the activity of the ok-Npt2 promoter in the OK cell line (Fig. 7A).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   Effect of different "stimuli" known to influence the activity of the type II Na-Pi cotransporter. OK cells (3B/2) were electroporated in presence of diverse pGL3 constructs. For each transfection, cells were equally plated in 24-well plates and after 4 h switched to fetal calf serum-free medium treated with 10-8 M parathyroid hormone (PTH) in DMEM-F12 at 5% CO2 (A) or with 0.1, 0.9 or 1.5 mM phosphate DMEM medium (Sigma) at 5% CO2 (B) for 24 h. In several experiments the cytomegalovirus (CMV) promoter activity of the vector used for standardization (pCMV-LacZ) was two- to threefold increased in presence of PTH. Therefore, we did not include the beta -galactosidase assay for standardization in A.

To prove that the transiently transfected cells responded to the stimuli, phosphate uptake was measured in parallel. We could report a 25-30% decrease in phosphate uptake upon addition of PTH and a 30-50% difference in phosphate uptake between 0.1 and 1.5 mM phosphate medium. These effects of PTH and Pi deprivation are somewhat lower than those previously reported (4, 17). One of the reasons for these differences is the use of subconfluent cells (present study) instead of confluent cells in the previous studies (4, 17).

    DISCUSSION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

Opossum kidney cells (OK cells) are the only renal cell line expressing the type II Na-Pi cotransporter (NaPi-4) in significant amounts. Furthermore, in this cell line the transporter is regulated like in the proximal tubule (for review see Refs. 13, 19-22). Therefore, OK cells are ideally suited in homologous transfection studies to characterize structure and function relationships of the type II Na-Pi cotransport promoter.

We report the characterization of the 5'-flanking region of the ok-Npt2 gene including the promoter region and exons 1 to 3. The first two exons are separated by a relatively small intron of 443 bp. Within the 5'-flanking region and adjacent to exon 3, two extended GGAA repeats (microsatellites) of unknown function are present. The promoter/enhancer region of the ok-Npt2 gene contains a typical TATA box and a conserved GCAAT element, which seem to enhance promoter activity. These motifs are also found at corresponding sites within the published human and murine type II Na-Pi cotransporter genes (Fig. 3). In all three species the translation start site is within the second exon. For both the murine and the OK cell Npt2 genes, the conserved TATA box is 31 bp away from the major transcription initiation site (see Fig. 3). In the ok-Npt2 gene an AP1 site is present at position -304; two AP1 sites have also been identified in the human NPT2 gene but are located further upstream (29).

In contrast to OK cells, no promoter activity could be observed in the human macrophage cell line U397, in the Madin Darby canine kidney MDCK cell line of distal tubular origin, and in the murine kidney cortex cell line MCT, and we could prove by RT-PCR and Northern blotting that in the human, murine, and dog cell lines an intrinsic type II Na-Pi cotransporter is absent (data not shown). These results indicate that an element might be present within the 327-bp fragment derived from the ok-Npt2 gene that promotes transcriptional activity in OK cells. The negative RT-PCR result with the murine cell line MCT, a SV40 transformed cell line derived from microdissected mice proximal tubules (10), indicates a lack of cell differentiation. In Northern hybridizations, we could also not observe an expression of the type II Na-Pi cotransporter in "proximal tubular" LLC-PK cells (17; data not shown). It remains unknown why only OK cells have retained the capacity to express the type II Na-Pi cotransporter in physiological relevant amounts and with the basic and regulatory characteristics of the type II Na-Pi cotransporter in its proximal tubular environment.

Dietary phosphorus and PTH are important regulators of renal phosphate reabsorption. Dietary phosphate restriction for several days leads in rats to an increased brush-border membrane type II Na-Pi cotransporter expression on protein and mRNA level that cannot be prevented by actinomycin D (14, 15). Interestingly, the early effects (2 h) are independent of changes in mRNA content. A similar phenomenon can also be observed in OK cells. In our studies Pi deprivation led to an increase in apical Na-Pi cotransport activity that could not be prevented by actinomycin D (4). Similar to the rat studies, Pi deprivation of OK cells (clone 3B/2) led at early time points to transport alterations not paralleled by alteration in mRNA content (18). Under chronic conditions (24 h), Pi deprivation of OK cells led to an increased apical expression of Na-Pi cotransport activity that was not always paralleled by an increase in mRNA content (Ref. 18; M. Custer and J. Biber, unpublished observations). These data suggest that Pi deprivation (in the diet or medium) leads to an altered Na-Pi cotransport activity that can occur independent of an increased transcription rate. The data obtained from the reporter gene studies with the ok-Npt2 promoter in the "responsive" OK cell environment are in direct support of the interpretations mentioned above.

For PTH we could recently show that inhibition of rat proximal tubular Na-Pi cotransport is related to a withdrawal of the protein from the apical surface; also, the mRNA level was found to be reduced after PTH administration (2 h) to parathyroidectomized rats (12). Similar results were obtained in the OK cell system, where PTH treatment leads in short-term experiments to a rapid internalization of the Na-Pi cotransporter protein from the apical membrane (23). The present reporter gene studies were not able to detect a change in type II Na-Pi cotransporter promoter activity after prolonged PTH treatment (24 h).

We have also performed reporter gene studies with additional hormones known to regulate the type II Na-Pi cotransporter in OK cells. Experiments were performed for 24 h with dexamethasone (10-6 M, see Ref. 31), T3 (10-7 M, see Ref. 28), with insulin-like growth factor I (10-7 M), and with epidermal growth factor (10-8 M, see Ref. 1). For all these conditions, we could not document reproducible and significant changes in transcriptional activity (data not shown). In contrast to our previous studies (~50% increase, see Ref. 28), we were unable to observe a T3-induced increase in specific mRNA content (data not shown). Although we have no satisfactory explanation for this apparent discrepancy, we must conclude that T3 effects on promoter activity seem to be rather small and that present experimental conditions (e.g., cell passage number and source of FCS in culture medium) might have prevented detection of small alterations in promoter activity and specific mRNA-content.

The present results indicate that the ok-Npt2 promoter is "constitutively" active and contains elements required for cell-specific expression. We were unable to document large changes in promoter activity for different modulators of the type II Na-Pi cotransporter in renal cells (proximal tubule and OK cells), indicating that the protein abundance might be regulated predominantly at the posttranscriptional level.

    ACKNOWLEDGEMENTS

We thank Dr. R. Wuethrich for supplying us with various kidney cell lines, Dr. R. Wenger, Dr. J. Biber, and Dr. F. Verrey for helpful discussions, and C. Gasser for preparing the figures.

    FOOTNOTES

The nucleotide sequence reported in this study has been submitted to the GenBank/EMBL Data Bank with accession no. AJ003021.

This work was supported by a Swiss National Science Foundation Grants 32.30785 and 31.46523 (to H. Murer).

Address for reprint requests: H. Hilfiker, Institute of Physiology, Univ. of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.

Received 12 May 1997; accepted in final form 18 September 1997.

    REFERENCES
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References

1.   Arar, M., M. Baum, J. Biber, H. Murer, and M. Levi. Epidermal growth factor inhibits Na-Pi cotransport and mRNA in OK cells. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F309-F314, 1995[Abstract/Free Full Text].

2.   Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl. Current Protocols in Molecular Biology. New York: Wiley, 1995.

3.   Berndt, T. J., and F. G. Knox. Renal regulation of phosphate excretion. In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin, and G. Giebisch. New York: Raven, 1992, p. 2511-2532.

4.   Biber, J., J. Forgo, and H. Murer. Modulation of Na+-Pi cotransport in opossum kidney cells by extracellular phosphate. Am. J. Physiol. 255 (Cell Physiol. 24): C155-C161, 1988[Abstract/Free Full Text].

5.   Caverzasio, J., R. Rizzoli, and J. P. Bonjour. Sodium-dependent phosphate transport inhibited by parathyroid hormone and cyclic AMP stimulation in an opossum kidney cell line. J. Biol. Chem. 261: 3233-3237, 1986[Abstract/Free Full Text].

6.   Dennis, V. W. Phosphate homeostasis. In: Handbook of Physiology. Renal Physiology. Bethesda, MD: Am. Physiol. Soc., 1992, sect. 8, vol. 2, chapt. 37, p. 1785-1815.

7.   Frohman, M. A. PCR Protocols: A Guide to Methods and Applications, edited by M. A. Innes, D. H. Gelfand, J. J. Sninsky, and T. J. White. New York: Academic, 1990, p. 28-38.

8.   Hartmann, C. M., A. S. Hewson, C. H. Kos, H. Hilfiker, Y. Soumounou, H. Murer, and H. S. Tenenhouse. Structure of murine and human renal type II Na+-phosphate cotransporter genes (Npt2 and NPT2). Proc. Natl. Acad. Sci. USA 93: 7409-7414, 1996[Abstract/Free Full Text].

9.   Hartmann, C. M., C. A Wagner, A. E. Busch, D. Markovich, J. Biber, F. Lang, and H. Murer. Transport characteristics of a murine renal Na/Pi cotransporter. Pflügers Arch. 430: 830-836, 1995[Medline].

10.   Haverty, T. P., C. J. Kelly, W. H. Hines, P. S. Amenta, M. Watanabe, R. A. Harper, N. A. Kefalides, and E. G. Neilson. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 107: 1359-1368, 1988[Abstract/Free Full Text].

11.   Helps, C., H. Murer, and J. McGivan. Cloning, sequence analysis and expression of the cDNA encoding a sodium-dependent phosphate transporter from the bovine renal epithelial cell line NBL. Pflügers Arch. 228: 927-930, 1995.

12.   Kempson, S. A., M. Lotscher, B. Kaissling, J. Biber, H. Murer, and M. Levi. Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F784-F791, 1995[Abstract/Free Full Text].

13.   Levi, M., S. A. Kempson, M. Lotscher, J. Biber, and H. Murer. Molecular regulation of renal phosphate transport. J. Membr. Biol. 154: 1-9, 1996[Medline].

14.   Levi, M., M. Lotscher, V. Sorribas, M. Custer, M. Arar, B. Kaissling, H. Murer, and J. Biber. Cellular mechanisms of acute and chronic adaptation of rat renal Pi transporter to alterations in dietary Pi. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F900-F908, 1994[Abstract/Free Full Text].

15.   Lotscher, M., B. Kaissling, J. Biber, H. Murer, and M. Levi. Role of microtubules in the rapid regulation of renal phosphate transport in response to acute alterations in dietary phosphate content. J. Clin. Invest. 99: 1302-1312, 1997[Medline].

16.   Magagnin, S., A. Werner, D. Markovich, V. Sorribas, G. Stange, J. Biber, and H. Murer. Expression cloning of human and rat renal cortex Na/Pi cotransport. Proc. Natl. Acad. Sci. USA 90: 5979-5983, 1993[Abstract/Free Full Text].

17.   Malmström, K., and H. Murer. Parathyroid hormone inhibits phosphate transport in OK cells but not in LLC-PK1 and JTC-12.P3 cells. Am. J. Physiol. 251 (Cell Physiol. 20): C23-C31, 1986[Abstract/Free Full Text].

18.   Markovich, D., T. Verri, V. Sorribas, J. Forgo, J. Biber, and H. Murer. Regulation of opossum kidney (OK) cell Na/Pi cotransport by Pi deprivation involves mRNA stability. Pflügers Arch. 430: 459-463, 1995[Medline].

19.   Murer, H., and J. Biber. A molecular view of proximal tubular inorganic phosphate (Pi) reabsorption and of its regulation. Pflügers Arch. 433: 379-389, 1997[Medline].

20.   Murer, H., and J. Biber. Molecular mechanisms of renal apical Na/phosphate cotransport. Annu. Rev. Physiol. 58: 607-618, 1996[Medline].

21.   Murer, H., and J. Biber. Renal sodium-phosphate cotransport. Curr. Opin. Nephrol. Hypertens. 3: 504-510, 1994[Medline].

22.   Murer, H., and J. Biber. Renal tubular phosphate transport: cellular mechanisms. In: The Kidney: Physiology and Pathophysiology, edited by D. W. Seldin, and G. Giebisch. New York: Raven, 1992, p. 481-509.

23.   Pfister, M. F., E. Lederer, J. Forgo, U. Ziegler, M. Lotscher, E. S. Quabius, J. Biber, and H. Murer. Parathyroid hormone-dependent degradation of type II Na+/Pi cotransporters. J. Biol. Chem. 272: 20125-20130, 1997[Abstract/Free Full Text].

23a.   Quamme, G., S. Pelech, J. Biber, and H. Murer. Abnormalities of parathyroid hormone-mediated signal transduction mechanisms in opossum kidney cells. Biochim. Biophys. Acta 1223: 107-116, 1994[Medline].

24.   Reshkin, S. J., J. Forgo, and H. Murer. Functional asymmetry of phosphate transport and its regulation in opossum kidney cells: phosphate transport. Pflügers Arch. 416: 624-631, 1990[Medline].

25.   Saxena, S., and M. Allon. The role of cytosolic calcium in chronic adaptation to phosphate depletion in opossum kidney cells. J. Biol. Chem. 271: 3902-3906, 1996[Abstract/Free Full Text].

26.   Saxena, S., L. Dansby, and M. Allon. Adaptation to phosphate depletion in opossum kidney cells. Biochem. Biophys. Res. Commun. 216: 141-147, 1995[Medline].

27.   Sorribas, V., D. Markovich, G. Hayes, G. Stange, J. Forgo, J. Biber, and H. Murer. Cloning of a Na/Pi cotransporter from opossum kidney cells. J. Biol. Chem. 269: 6615-6621, 1994[Abstract/Free Full Text].

28.   Sorribas, V., D. Markovich, T. Verri, J. Biber, and H. Murer. Thyroid hormone stimulation of Na/Pi-cotransport in opossum kidney cells. Pflügers Arch. 431: 266-271, 1995[Medline].

29.   Taketani, Y., K.-I. Miyamoto, K. Katai, M. Chikamori, S. Tatsumi, H. Segawa, H. Yamamoto, K. Morita, and E. Takeda. Gene structure and functional analysis of the human Na+/phosphate co-transporter. Biochem. J. 324: 927-934, 1997.

30.   Verri, T., D. Markovich, C. Perego, F. Norbis, G. Stange, V. Sorribas, J. Biber, and H. Murer. Cloning of a rabbit renal Na-Pi cotransporter, which is regulated by dietary phosphate. Am. J. Physiol. 268 (Renal Fluid Electrolyte Physiol. 37): F626-F633, 1995[Abstract/Free Full Text].

31.   Vrtovsnik, F., M. Jourdain, G. Cherqui, J. Lefebvre, and G. Friedlander. Glucocorticoid inhibition of Na-Pi cotransport in renal epithelial cells is mediated by protein kinase C. J. Biol. Chem. 269: 8872-8877, 1994[Abstract/Free Full Text].

32.   Werner, A., H. Murer, and R. K. H. Kinne. Cloning and expression of a renal Na-Pi cotransport system from flounder. Am. J. Physiol. 267 (Renal Fluid Electrolyte Physiol. 36): F311-F317, 1994[Abstract/Free Full Text].


AJP Renal Physiol 274(1):F197-F204
0363-6127/98 $5.00 Copyright © 1998 the American Physiological Society




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hilfiker, H.
Right arrow Articles by Murer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hilfiker, H.
Right arrow Articles by Murer, H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online